NCT01060137View on ClinicalTrials.gov

Fentanyl Matrix in Lung Cancer Pain

PHASE4CompletedINTERVENTIONAL

Enrollment

268

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Lung CancerPain

Interventions

DRUG

fentanyl matrix

Fentanyl transdermal patch 12 - 25mcg/hr

All Listed Sponsors

lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT01060137 - Fentanyl Matrix in Lung Cancer Pain | Biotech Hunter | Biotech Hunter